• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用脂质体包裹的放线菌素D治疗荷瘤小鼠可延长其生存期。

Treatment of tumour bearing mice with liponsome-entrapped actinomycin D prolongs their survival.

作者信息

Gregoriadis G, Neerunjun E D

出版信息

Res Commun Chem Pathol Pharmacol. 1975 Feb;10(2):351-62.

PMID:1153840
Abstract

The possibility of employing liposome-entrapped actinomycin D for the treatment of AKR mice inoculated with AKR-A cells was examined. It was found that injection of actinomycin D after its entrapment in liposomes prolonged the survival of such mice to a greater extent than did similar amounts of free actinomycin D. Data from in vitro experiments suggest that entrapped actinomycin D could localize in the nucleus of AKR-A cells presumably following endocytosis of the liposomal carrier and subsequent liberation of the drug in, and its diffusion from, the lysosomes.

摘要

研究了采用脂质体包裹的放线菌素D治疗接种AKR - A细胞的AKR小鼠的可能性。结果发现,脂质体包裹后的放线菌素D注射比等量游离放线菌素D能更大程度地延长此类小鼠的存活时间。体外实验数据表明,包裹的放线菌素D可能在脂质体载体被内吞后,在溶酶体中释放并扩散,从而定位于AKR - A细胞的细胞核中。

相似文献

1
Treatment of tumour bearing mice with liponsome-entrapped actinomycin D prolongs their survival.用脂质体包裹的放线菌素D治疗荷瘤小鼠可延长其生存期。
Res Commun Chem Pathol Pharmacol. 1975 Feb;10(2):351-62.
2
Antitumor effect of actinomycin D entrapped in liposomes bearing subunits of tumor-specific monoclonal immunoglobulin M antibody.包裹有肿瘤特异性单克隆免疫球蛋白M抗体亚基的脂质体包封放线菌素D的抗肿瘤作用。
Cancer Res. 1983 Nov;43(11):5328-34.
3
Failure of actinomycin D entrapped in liposomes to prolong survival in renal cell adenocarcinoma-bearing mice.包裹在脂质体中的放线菌素D未能延长荷肾细胞腺癌小鼠的生存期。
Oncology. 1981;38(5):311-4. doi: 10.1159/000225577.
4
Enhancement of adriamycin delivery to liver metastatic cells with increased tumoricidal effect using liposomes as drug carriers.使用脂质体作为药物载体增强阿霉素向肝转移细胞的递送并提高杀肿瘤效果。
Cancer Res. 1983 Oct;43(10):4730-5.
5
The effect of liposome-entrapped specific cell growth inhibitor (chalone) on tumour cell proliferation.脂质体包裹的特异性细胞生长抑制剂(抑素)对肿瘤细胞增殖的影响。
J Microencapsul. 1988 Jan-Mar;5(1):59-64. doi: 10.3109/02652048809036723.
6
Some determinants of the therapeutic efficacy of actinomycin D (NSC-3053), adriamycin (NSC-123127), and daunorubicin (NSC-83142).
Cancer Chemother Rep. 1974 Jan-Feb;58(1):55-62.
7
Ultrasound triggered release of cisplatin from liposomes in murine tumors.超声触发顺铂从脂质体在小鼠肿瘤中的释放。
J Control Release. 2009 Jul 1;137(1):63-8. doi: 10.1016/j.jconrel.2009.03.007. Epub 2009 Mar 19.
8
Specific enhancement of drug delivery to AKR lymphoma by antibody-targeted small unilamellar vesicles.通过抗体靶向小单层囊泡特异性增强药物向AKR淋巴瘤的递送。
Cancer Res. 1984 May;44(5):1880-6.
9
Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.脂质体与热疗在人肿瘤异种移植模型中的疗效:触发药物释放的重要性。
Cancer Res. 2000 Dec 15;60(24):6950-7.
10
Effects of liposome-entrapped doxorubicin on liver metastases of mouse colon carcinomas 26 and 38.
J Natl Cancer Inst. 1987 Apr;78(4):707-13.

引用本文的文献

1
Liposomes in Cancer Therapy: How Did We Start and Where Are We Now.脂质体在癌症治疗中的应用:我们从何出发,又身在何处。
Int J Mol Sci. 2023 Apr 1;24(7):6615. doi: 10.3390/ijms24076615.
2
Synthetic nanoparticles of bovine serum albumin with entrapped salicylic acid.包载水杨酸的牛血清白蛋白合成纳米颗粒。
Nanotechnol Sci Appl. 2016 Dec 28;10:11-21. doi: 10.2147/NSA.S117018. eCollection 2017.
3
Liposomes in Drug Delivery: How It All Happened.脂质体药物递送:一切是如何发生的。
Pharmaceutics. 2016 May 24;8(2):19. doi: 10.3390/pharmaceutics8020019.
4
Functionalization of immunostimulating complexes (ISCOMs) with lipid vinyl sulfones and their application in immunological techniques and therapy.免疫刺激复合物(ISCOMs)与脂质乙烯砜的功能化及其在免疫技术和治疗中的应用。
Int J Nanomedicine. 2012;7:5941-56. doi: 10.2147/IJN.S35556. Epub 2012 Dec 3.
5
Zinc oxide nanoparticles for selective destruction of tumor cells and potential for drug delivery applications.氧化锌纳米颗粒用于选择性破坏肿瘤细胞和药物输送应用的潜力。
Expert Opin Drug Deliv. 2010 Sep;7(9):1063-77. doi: 10.1517/17425247.2010.502560.
6
Liposomes as carriers of cancer chemotherapy. Current status and future prospects.脂质体作为癌症化疗的载体。现状与未来展望。
Drugs. 1993 Oct;46(4):618-38. doi: 10.2165/00003495-199346040-00004.
7
Increased therapeutic efficiency of a lipid-soluble alkylating agent incorporated in liposomes.脂质体包裹的脂溶性烷化剂治疗效率提高。
Br J Cancer. 1982 Jun;45(6):830-4. doi: 10.1038/bjc.1982.134.
8
Effect of liposomally trapped antitumour drugs on a drug-resistant mouse lymphoma in vivo.脂质体包裹的抗肿瘤药物对体内耐药小鼠淋巴瘤的作用。
Br J Cancer. 1982 Apr;45(4):552-8. doi: 10.1038/bjc.1982.91.
9
Suppression of liver uptake of liposomes by dextran sulfate 500.硫酸葡聚糖500对脂质体肝脏摄取的抑制作用
Proc Natl Acad Sci U S A. 1983 Nov;80(21):6518-22. doi: 10.1073/pnas.80.21.6518.
10
Potential of liposomes as drug-carriers in cancer chemotherapy: a review.脂质体作为癌症化疗药物载体的潜力:综述
Cancer Chemother Pharmacol. 1979;3(2):81-5. doi: 10.1007/BF00254977.